Igmorino®

Our team has developed a revolutionary, internationally patented, upper respiratory cleansing device (Igmorino®), that achieves flooding of the nasal cavity, maxillary and ethmoidal sinuses and frontal chambers with any therapeutic liquid chosen. Our device does not rely on injection pressure and is painless and comfortable to the user, and also allows him/her to keep the paranasal and nasal cavities flooded for as long as it’s needed, for the therapeutic liquid to take action. Recently we applied Igmorino® with a hypertonic 3,6% solution, to two positively tested to COVID-19 patients with a high viral load of 20,6 and 20,8 Ct value. The patients’ nasal and throat swabs were taken and tested daily and after 2-4 days of Igmorino’s application (3-4 applications/day), both of the patients were found to be NEGATIVE to COVID-19. Our next step is to propose and conduct a large scale (<150 patients), small duration (14 day/patient) research, in order to validate our indications above.

Built With

• device
• hardware
• medical